Misregulated progesterone secretion and impaired pregnancy in Cyp11a1 transgenic mice

Biology of Reproduction

Volumn 89, Issue 4, 2013, Pages

  Chien, Yu ^a,b   Cheng, Wei Cheng ^b   Wu, Menq Rong ^b   Jiang, Si Tse ^b,c   Shen, Che Kun James ^b   Chung, Bon chu ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c NATIONAL APPLIED RESEARCH LABORATORIES   (Taiwan)

Author keywords

Corpus luteum; Cyp11a1; Decidua; Embryo implantation; Ovary; P450scc; Placenta; Pregnancy; Progesterone; Reproduction; Steroidogenesis

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); FAT DROPLET;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; HUMAN; LITTER SIZE; LUTEAL CELL; PREGNANCY DISORDER; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROTEIN EXPRESSION; STEROIDOGENESIS;

CORPUS LUTEUM; CYP11A1; DECIDUA; EMBRYO IMPLANTATION; OVARY; P450SCC; PLACENTA; PREGNANCY; PROGESTERONE; REPRODUCTION; STEROIDOGENESIS;

ANIMALS; CELL DIFFERENTIATION; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CORPUS LUTEUM MAINTENANCE; CROSSES, GENETIC; DECIDUA; EMBRYO IMPLANTATION; FEMALE; HORMONE REPLACEMENT THERAPY; INFERTILITY, FEMALE; LIPID METABOLISM; LITTER SIZE; LUTEAL CELLS; LUTEINIZATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA; PLACENTATION; PREGNANCY; PROGESTERONE; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84899832924     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.110833     Document Type: Article

References (38)

1. Bachelot A, Binart N. Corpus luteum development: lessons from genetic models in mice. Curr Top Dev Biol 2005; 68:49-84.
2. Large MJ, DeMayo FJ. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol Cell Endocrinol 2012; 358:155-165.
3. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med 2012; 18:1754-1767.
4. Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C. Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol Rev 2006; 214:161-185.
5. Pollard JW. Uterine DCs are essential for pregnancy. J Clin Invest 2008; 118:3832-3835.
6. Blois SM, Klapp BF, Barrientos G. Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. J Reprod Immunol 2011; 88:86-92.
7. Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998; 392: 509-512.
8. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M, Hasumoto K, Murata T, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997; 277:681-683.
9. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A 2010; 107:20828-20833.
10. Mendelson CR. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol 2009; 23:947-954.
11. Virgo BB, Bellward GD. Serum progesterone levels in the pregnant and postpartum laboratory mouse. Endocrinology 1974; 95:1486-1490.
12. Murr SM, Stabenfeldt GH, Bradford GE, Geschwind II. Plasma progesterone during pregnancy in the mouse. Endocrinology 1974; 94: 1209-1211.
13. Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981; 114:209-217.
14. Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 2007; 28:117-149.
15. Devoto L, Kohen P, Vega M, Castro O, Gonzalez RR, Retamales I, Carvallo P, Christenson LK, Strauss JF. Control of human luteal steroidogenesis. Mol Cell Endocrinol 2002; 186:137-141.
16. Miller WL. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 2005; 146:2544-2550.
17. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32:81-151.
18. Hu MC, Hsu HJ, Guo IC, Chung BC. Function of Cyp11a1 in animal models. Mol Cell Endocrinol 2004; 215:95-100.
19. Shih MC, Chiu YN, Hu MC, Guo IC, Chung BC. Regulation of steroid production: analysis of Cyp11a1 promoter. Mol Cell Endocrinol 2011; 336:80-84.
20. Yaspan BL, Breyer JP, Cai Q, Dai Q, Elmore JB, Amundson I, Bradley KM, Shu XO, Gao YT, Dupont WD, Zheng W, Smith JR. Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Cancer Res 2007; 67:5673-5682.
21. Wickenheisser JK, Biegler JM, Nelson-Degrave VL, Legro RS, Strauss JF, 3rd, McAllister JM. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS One 2012; 7:e48963.
22. Strauss JF III. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci 2003; 997:42-48.
23. Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL. Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 2008; 93:696-702.
24. Tee MK, Abramsohn M, Loewenthal N, Harris M, Siwach S, Kaplinsky A, Markus B, Birk O, Sheffield VC, Pavari R, Hershkovitz E, Miller WL. Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 2013; 98:713-720.
25. Hsu HJ, Hsu NC, Hu MC, Chung BC. Steroidogenesis in zebrafish and mouse models. Mol Cell Endocrinol 2006; 248:160-163.
26. Huang CC, Shih MC, Hsu NC, Chien Y, Chung BC. Fetal glucocorticoid synthesis is required for development of fetal adrenal medulla and hypothalamus feedback suppression. Endocrinology 2012; 153: 4749-4756.
27. Hu MC, Guo IC, Lin JH, Chung BC. Regulated expression of cytochrome P-450scc (cholesterol-side-chain cleavage enzyme) in cultured cell lines detected by antibody against bacterially expressed human protein. Biochem J 1991; 274:813-817.
28. Hu MC, Hsu NC, El Hadj NB, Pai CI, Chu HP, Wang CK, Chung BC. Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol 2002; 16:1943-1950.
29. Russ AP, Wattler S, Colledge WH, Aparicio SA, Carlton MB, Pearce JJ, Barton SC, Surani MA, Ryan K, Nehls MC, Wilson V, Evans MJ. Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature 2000; 404:95-99.
30. Soares MJ, Chakraborty D. Karim Rumi MA, Konno T, Renaud SJ. Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface. Placenta 2012; 33:233-243.
31. Kidder BL, Palmer S. Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenance. Genome Res 2010; 20:458-472.
32. Tayade C, Fang Y, Black GP. V AP Jr, Erlebacher A, Croy BA. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells. J Leukoc Biol 2005; 78:1347-1355.
33. Arensburg J, Payne AH, Orly J. Expression of steroidogenic genes in maternal and extraembryonic cells during early pregnancy in mice. Endocrinology 1999; 140:5220-5232.
34. Schiff R, Arensburg J, Itin A, Keshet E, Expression Orly J. and cellular localization of uterine side-chain cleavage cytochrome P450 messenger ribonucleic acid during early pregnancy in mice. Endocrinology 1993; 133:529-537.
35. Mitchell BF, Taggart MJ. Are animal models relevant to key aspects of human parturition? Am J Physiol Regul Integr Comp Physiol 2009; 297: R525-545.
36. Ratajczak CK, Muglia LJ. Insights into parturition biology from genetically altered mice. Pediatr Res 2008; 64:581-589.
37. Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006; 24:33-39.
38. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999; 340:1796-1799.